Drug intelligence / Profile preview

tripterygium wilfordii polyglycosides

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Tripterygium wilfordii polyglycosides is an oral botanical extract derived from the roots of Tripterygium wilfordii Hook F., a traditional Chinese medicinal plant. It contains multiple active compounds including triptolide, triptonide, celastrol, and wilforine. The drug exhibits potent anti-inflammatory and immunosuppressive effects by modulating immune cell activity (notably T cells and dendritic cells), suppressing inflammatory cytokine production (such as IL-6 and IL-8), reducing neutrophil elastase activity, and regulating cellular signaling pathways involved in inflammation. It is primarily used for the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, chronic glomerulonephritis (including primary membranous nephropathy and diabetic kidney disease), psoriasis, and other rheumatic or immune-mediated conditions[1][2][7][9][10]. Clinical studies have shown that it can reduce proteinuria in kidney diseases and improve remission rates in autoimmune disorders with a safety profile comparable to glucocorticoids when monitored appropriately[7][9]. However, its use is limited by potential toxicity affecting multiple organ systems due to its narrow therapeutic window[3].

Brand names
Tripterygium Glycoside TabletsTripterygium wilfordii Tablets
Other names
tripterygium wilfordii glycosidesTWPTWPTTripterygium wilfordii poly-glycosides
02

Targets

IL-6 (Interleukin 6)IL8 (C-X-C Motif Chemokine Ligand 8)ELANE (Human Neutrophil Elastase)

Beyond the preview

Go deeper on tripterygium wilfordii polyglycosides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tripterygium wilfordii polyglycosides.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call